{"id":"NCT02292537","sponsor":"Biogen","briefTitle":"A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)","officialTitle":"A Phase 3, Randomized, Double-blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients With Later-onset Spinal Muscular Atrophy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-24","primaryCompletion":"2017-02-20","completion":"2017-02-20","firstPosted":"2014-11-17","resultsPosted":"2018-02-22","lastUpdate":"2021-02-17"},"enrollment":126,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Spinal Muscular Atrophy"],"interventions":[{"type":"DRUG","name":"Nusinersen","otherNames":["Sprinraza","ISIS 396443","IONIS-SMN Rx","BIIB058"]},{"type":"PROCEDURE","name":"Sham procedure","otherNames":[]}],"arms":[{"label":"Nusinersen","type":"EXPERIMENTAL"},{"label":"Sham procedure","type":"SHAM_COMPARATOR"}],"summary":"The primary objective of this study is to examine the clinical efficacy of nusinersen (ISIS 396443) administered intrathecally to participants with later-onset Spinal Muscular Atrophy (SMA). The secondary objective is to examine the safety and tolerability of nusinersen administered intrathecally to participants with later-onset SMA.","primaryOutcome":{"measure":"Change From Baseline in Hammersmith Functional Motor Scale - Expanded (HFMSE) Score at Month 15","timeFrame":"Baseline and Month 15","effectByArm":[{"arm":"Sham Procedure","deltaMin":-1,"sd":null},{"arm":"Nusinersen","deltaMin":3.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0000001"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":13},"locations":{"siteCount":24,"countries":["United States","Canada","France","Germany","Hong Kong","Italy","Japan","South Korea","Spain","Sweden"]},"refs":{"pmids":["31420846","29443664"],"seeAlso":["http://www.curesma.org","http://mda.org/disease/spinal-muscular-atrophy","https://www.rarediseases.org"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":42},"commonTop":["Pyrexia","Upper respiratory tract infection","Nasopharyngitis","Cough","Vomiting"]}}